The effectiveness of private drug plan programs, new subsequent entry biologic (biosimilar) policies as well as opportunities for improved transparency and collaboration were under the spotlight at the 3rd Annual Benefits Advisors’ Drug Plan Outlook. Mapol Inc. brought together benefits advisors from across Canada with representatives of Canada’s brand pharmaceutical manufacturers on November 3, 2016. Read more ...
Read Article Online - Page 38-41
Mapol's 4th Annual Benefits Advisors’ Drug Plan Outlook Meeting will be in December 2017 in Toronto. For information on sponsorship opportunities, please contact Corinne Razem at email@example.com